North America Dementia Treatment Market Size, Share & Trends Analysis Report By Type, By Dementia Drugs Route of Administration, By Dementia Drugs Distribution Channel, By Indication, By Country and Growth Forecast, 2024

List of Tables

The North America Dementia Treatment Market would witness market growth of 6.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Dementia Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $7,858.8 million by 2031. The Canada market is experiencing a CAGR of 9.3% during (2024 - 2031). Additionally, The Mexico market would witness a CAGR of 8.3% during (2024 - 2031).

Dementia is a comprehensive collection of brain diseases that cause a significant and often gradual erosion of an individual's ability to think and remember, thereby significantly affecting their daily life. As one of the most prevalent forms of dementia, Alzheimer's disease accounts for approximately 60-70% of cases. Additional types of dementia include frontotemporal dementia, vascular dementia, and Lewy body dementia.

The prevalence of dementia is increasing at a rapid pace, which requires substantial progress in its treatment and management as the global population ages. This burgeoning prevalence, coupled with the immense societal and economic burden it imposes, has catalyzed the development of the dementia treatment market. Numerous services and products are currently available on the market with the intention of diagnosing, treating, and managing dementia-related conditions. These conditions include Alzheimer's disease, Lewy body dementia, vascular dementia, and frontotemporal dementia, among others.

Mexico is also witnessing a rise in the demand for dementia treatment due to the increasing prevalence of dementia and ongoing research efforts. According to a study published by the National Institute of Public Health (INSP) of Mexico, the number of people living with dementia in Mexico is expected to grow from approximately 800,000 in 2020 to over 1.5 million by 2050. The aging population, as well as increased life expectancy, are the primary factors contributing to this increase. Hence, the region will present lucrative growth opportunities for the market throughout the forecast period.

Based on Type, the market is segmented into Diagnosis (Imaging Techniques, Cognitive Assessment Tools, Genetic Testing, Biomarker Analysis and Others) and Drugs (Cholinesterase Inhibitors, NMDA Receptor Antagonist, MAO Inhibitors, Combination Drug and Others). Based on Dementia Drugs Route of Administration, the market is segmented into Oral, Transdermal Patch, and Injectable. Based on Dementia Drugs Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on Indication, the market is segmented into Alzheimer's Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia (FTD), Parkinson Disease Dementia and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Eisai Co., Ltd.
Eli Lilly And Company
F. Hoffmann-La Roche Ltd.
Biogen, Inc.
AbbVie, Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline PLC (GSK)
Cipla Limited

North America Dementia Treatment Market Report Segmentation

By Type

Diagnosis
- Imaging Techniques
- Cognitive Assessment Tools
- Genetic Testing
- Biomarker Analysis
- Others
Drugs
- Cholinesterase Inhibitors
- NMDA Receptor Antagonist
- MAO Inhibitors
- Combination Drug
- Others

By Dementia Drugs Route of Administration

Oral
Transdermal Patch
Injectable

By Dementia Drugs Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Indication

Alzheimer's Disease Dementia
Vascular Dementia
Lewy Body Dementia
Frontotemporal Dementia (FTD)
Parkinson Disease Dementia
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Dementia Treatment Market, by Type
- 1.4.2 North America Dementia Treatment Market, by Dementia Drugs Route of Administration
- 1.4.3 North America Dementia Treatment Market, by Dementia Drugs Distribution Channel
- 1.4.4 North America Dementia Treatment Market, by Indication
- 1.4.5 North America Dementia Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Dementia Treatment Market by Type

4.1 North America Diagnosis Market by Region
4.2 North America Dementia Treatment Market by Diagnosis Type
- 4.2.1 North America Imaging Techniques Market by Country
- 4.2.2 North America Cognitive Assessment Tools Market by Country
- 4.2.3 North America Genetic Testing Market by Country
- 4.2.4 North America Biomarker Analysis Market by Country
- 4.2.5 North America Others Market by Country
4.3 North America Drugs Market by Region
4.4 North America Dementia Treatment Market by Drug Class
- 4.4.1 North America Cholinesterase Inhibitors Market by Country
- 4.4.2 North America NMDA Receptor Antagonist Market by Country
- 4.4.3 North America MAO Inhibitors Market by Country
- 4.4.4 North America Combination Drug Market by Country
- 4.4.5 North America Others Market by Country

Chapter 5. North America Dementia Treatment Market by Dementia Drugs Route of Administration

5.1 North America Oral Market by Country
5.2 North America Transdermal Patch Market by Country
5.3 North America Injectable Market by Country

Chapter 6. North America Dementia Treatment Market by Dementia Drugs Distribution Channel

6.1 North America Hospital Pharmacy Market by Country
6.2 North America Retail Pharmacy Market by Country
6.3 North America Online Pharmacy Market by Country

Chapter 7. North America Dementia Treatment Market by Indication

7.1 North America Alzheimer's Disease Dementia Market by Country
7.2 North America Vascular Dementia Market by Country
7.3 North America Lewy Body Dementia Market by Country
7.4 North America Frontotemporal Dementia (FTD) Market by Country
7.5 North America Parkinson Disease Dementia Market by Country
7.6 North America Others Market by Country

Chapter 8. North America Dementia Treatment Market by Country

8.1 US Dementia Treatment Market
- 8.1.1 US Dementia Treatment Market by Type
  - 8.1.1.1 US Dementia Treatment Market by Diagnosis Type
  - 8.1.1.2 US Dementia Treatment Market by Drug Class
- 8.1.2 US Dementia Treatment Market by Dementia Drugs Route of Administration
- 8.1.3 US Dementia Treatment Market by Dementia Drugs Distribution Channel
- 8.1.4 US Dementia Treatment Market by Indication
8.2 Canada Dementia Treatment Market
- 8.2.1 Canada Dementia Treatment Market by Type
  - 8.2.1.1 Canada Dementia Treatment Market by Diagnosis Type
  - 8.2.1.2 Canada Dementia Treatment Market by Drug Class
- 8.2.2 Canada Dementia Treatment Market by Dementia Drugs Route of Administration
- 8.2.3 Canada Dementia Treatment Market by Dementia Drugs Distribution Channel
- 8.2.4 Canada Dementia Treatment Market by Indication
8.3 Mexico Dementia Treatment Market
- 8.3.1 Mexico Dementia Treatment Market by Type
  - 8.3.1.1 Mexico Dementia Treatment Market by Diagnosis Type
  - 8.3.1.2 Mexico Dementia Treatment Market by Drug Class
- 8.3.2 Mexico Dementia Treatment Market by Dementia Drugs Route of Administration
- 8.3.3 Mexico Dementia Treatment Market by Dementia Drugs Distribution Channel
- 8.3.4 Mexico Dementia Treatment Market by Indication
8.4 Rest of North America Dementia Treatment Market
- 8.4.1 Rest of North America Dementia Treatment Market by Type
  - 8.4.1.1 Rest of North America Dementia Treatment Market by Diagnosis Type
  - 8.4.1.2 Rest of North America Dementia Treatment Market by Drug Class
- 8.4.2 Rest of North America Dementia Treatment Market by Dementia Drugs Route of Administration
- 8.4.3 Rest of North America Dementia Treatment Market by Dementia Drugs Distribution Channel
- 8.4.4 Rest of North America Dementia Treatment Market by Indication

Chapter 9. Company Profiles

9.1 Eisai Co., Ltd.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Trails and Approval:
- 9.1.6 SWOT Analysis
9.2 Eli Lilly And Company
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
9.3 F. Hoffmann-La Roche Ltd.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.6 SWOT Analysis
9.4 Biogen, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
9.5 AbbVie, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
9.6 Novartis AG
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 SWOT Analysis
9.7 Sun Pharmaceutical Industries Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Takeda Pharmaceutical Company Limited
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 GlaxoSmithKline PLC (GSK)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis
9.10. Cipla Limited
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Dementia Treatment Market, 2020 - 2023, USD Million
TABLE 2 North America Dementia Treatment Market, 2024 - 2031, USD Million
TABLE 3 North America Dementia Treatment Market by Type, 2020 - 2023, USD Million
TABLE 4 North America Dementia Treatment Market by Type, 2024 - 2031, USD Million
TABLE 5 North America Diagnosis Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Diagnosis Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
TABLE 8 North America Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
TABLE 9 North America Imaging Techniques Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Imaging Techniques Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Cognitive Assessment Tools Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Cognitive Assessment Tools Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Genetic Testing Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Genetic Testing Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Biomarker Analysis Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Biomarker Analysis Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Drugs Market by Region, 2020 - 2023, USD Million
TABLE 20 North America Drugs Market by Region, 2024 - 2031, USD Million
TABLE 21 North America Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 22 North America Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 23 North America Cholinesterase Inhibitors Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Cholinesterase Inhibitors Market by Country, 2024 - 2031, USD Million
TABLE 25 North America NMDA Receptor Antagonist Market by Country, 2020 - 2023, USD Million
TABLE 26 North America NMDA Receptor Antagonist Market by Country, 2024 - 2031, USD Million
TABLE 27 North America MAO Inhibitors Market by Country, 2020 - 2023, USD Million
TABLE 28 North America MAO Inhibitors Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Combination Drug Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Combination Drug Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
TABLE 34 North America Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
TABLE 35 North America Oral Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Oral Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Transdermal Patch Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Transdermal Patch Market by Country, 2024 - 2031, USD Million
TABLE 39 North America Injectable Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Injectable Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
TABLE 42 North America Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
TABLE 43 North America Hospital Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Hospital Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Retail Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Retail Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 47 North America Online Pharmacy Market by Country, 2020 - 2023, USD Million
TABLE 48 North America Online Pharmacy Market by Country, 2024 - 2031, USD Million
TABLE 49 North America Dementia Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 50 North America Dementia Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 51 North America Alzheimer's Disease Dementia Market by Country, 2020 - 2023, USD Million
TABLE 52 North America Alzheimer's Disease Dementia Market by Country, 2024 - 2031, USD Million
TABLE 53 North America Vascular Dementia Market by Country, 2020 - 2023, USD Million
TABLE 54 North America Vascular Dementia Market by Country, 2024 - 2031, USD Million
TABLE 55 North America Lewy Body Dementia Market by Country, 2020 - 2023, USD Million
TABLE 56 North America Lewy Body Dementia Market by Country, 2024 - 2031, USD Million
TABLE 57 North America Frontotemporal Dementia (FTD) Market by Country, 2020 - 2023, USD Million
TABLE 58 North America Frontotemporal Dementia (FTD) Market by Country, 2024 - 2031, USD Million
TABLE 59 North America Parkinson Disease Dementia Market by Country, 2020 - 2023, USD Million
TABLE 60 North America Parkinson Disease Dementia Market by Country, 2024 - 2031, USD Million
TABLE 61 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 62 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 63 North America Dementia Treatment Market by Country, 2020 - 2023, USD Million
TABLE 64 North America Dementia Treatment Market by Country, 2024 - 2031, USD Million
TABLE 65 US Dementia Treatment Market, 2020 - 2023, USD Million
TABLE 66 US Dementia Treatment Market, 2024 - 2031, USD Million
TABLE 67 US Dementia Treatment Market by Type, 2020 - 2023, USD Million
TABLE 68 US Dementia Treatment Market by Type, 2024 - 2031, USD Million
TABLE 69 US Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
TABLE 70 US Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
TABLE 71 US Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 72 US Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 73 US Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
TABLE 74 US Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
TABLE 75 US Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
TABLE 76 US Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
TABLE 77 US Dementia Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 78 US Dementia Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 79 Canada Dementia Treatment Market, 2020 - 2023, USD Million
TABLE 80 Canada Dementia Treatment Market, 2024 - 2031, USD Million
TABLE 81 Canada Dementia Treatment Market by Type, 2020 - 2023, USD Million
TABLE 82 Canada Dementia Treatment Market by Type, 2024 - 2031, USD Million
TABLE 83 Canada Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
TABLE 84 Canada Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
TABLE 85 Canada Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 86 Canada Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 87 Canada Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
TABLE 88 Canada Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
TABLE 89 Canada Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
TABLE 90 Canada Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
TABLE 91 Canada Dementia Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 92 Canada Dementia Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 93 Mexico Dementia Treatment Market, 2020 - 2023, USD Million
TABLE 94 Mexico Dementia Treatment Market, 2024 - 2031, USD Million
TABLE 95 Mexico Dementia Treatment Market by Type, 2020 - 2023, USD Million
TABLE 96 Mexico Dementia Treatment Market by Type, 2024 - 2031, USD Million
TABLE 97 Mexico Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
TABLE 98 Mexico Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
TABLE 99 Mexico Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 100 Mexico Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 101 Mexico Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
TABLE 102 Mexico Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
TABLE 103 Mexico Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
TABLE 104 Mexico Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
TABLE 105 Mexico Dementia Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 106 Mexico Dementia Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 107 Rest of North America Dementia Treatment Market, 2020 - 2023, USD Million
TABLE 108 Rest of North America Dementia Treatment Market, 2024 - 2031, USD Million
TABLE 109 Rest of North America Dementia Treatment Market by Type, 2020 - 2023, USD Million
TABLE 110 Rest of North America Dementia Treatment Market by Type, 2024 - 2031, USD Million
TABLE 111 Rest of North America Dementia Treatment Market by Diagnosis Type, 2020 - 2023, USD Million
TABLE 112 Rest of North America Dementia Treatment Market by Diagnosis Type, 2024 - 2031, USD Million
TABLE 113 Rest of North America Dementia Treatment Market by Drug Class, 2020 - 2023, USD Million
TABLE 114 Rest of North America Dementia Treatment Market by Drug Class, 2024 - 2031, USD Million
TABLE 115 Rest of North America Dementia Treatment Market by Dementia Drugs Route of Administration, 2020 - 2023, USD Million
TABLE 116 Rest of North America Dementia Treatment Market by Dementia Drugs Route of Administration, 2024 - 2031, USD Million
TABLE 117 Rest of North America Dementia Treatment Market by Dementia Drugs Distribution Channel, 2020 - 2023, USD Million
TABLE 118 Rest of North America Dementia Treatment Market by Dementia Drugs Distribution Channel, 2024 - 2031, USD Million
TABLE 119 Rest of North America Dementia Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 120 Rest of North America Dementia Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 121 Key Information - Eisai Co., Ltd.
TABLE 122 Key Information - Eli Lilly And Company
TABLE 123 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 124 Key Information - Biogen, Inc.
TABLE 125 Key information - AbbVie, Inc.
TABLE 126 Key Information - Novartis AG
TABLE 127 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 128 Key Information - Takeda Pharmaceutical Company Limited
TABLE 129 Key Information - GlaxoSmithKline PLC
TABLE 130 Key Information - Cipla Limited

North America Dementia Treatment Market Size, Share & Trends Analysis Report By Type, By Dementia Drugs Route of Administration, By Dementia Drugs Distribution Channel, By Indication, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents